The United States is more than eight months into the pandemic and people are back waiting in long lines to be tested as coronavirus infections surge again. And yet there is still no federal standard to ensure testing results are being uniformly reported. Without uniform results, it is impossible to track cases accurately or respond effectively.
We test to identify coronavirus infections in communities. We can tell if we are casting a wide enough net by looking at test positivity — the percentage of people whose results are positive for the virus. The metric tells us whether we are testing enough or if the transmission of the virus is outpacing our efforts to slow it.
If the percentage of tests coming back positive is low, it gives us more confidence that we are not missing a lot of infections. It can also tell us whether a recent surge in cases may be a result of increased testing, as President Trump has asserted, or that cases are rising faster than the rate at which communities are able to test.
But to interpret these results properly, we need a national standard for how these results are reported publicly by each state. And although the Centers for Disease Control and Prevention issue protocols for how to report new cases and deaths, there is no uniform guideline for states to report testing results, which would tell us about the universe of people tested so we know we are doing enough testing to track the disease. (Even the C.D.C. was found in May to be reporting states’ results in a way that presented a misleading picture of the pandemic.)
Without a standard, states are deciding how to calculate positivity rates on their own — and their approaches are very different.
Some states include results from positive antigen-based tests, some states don’t. Some report the number of people tested, while others report only the number of tests administered, which can skew the overall results when people are tested repeatedly (as, say, at colleges and nursing homes).
At one point in the spring, Texas, Virginia and Vermont were accused of reporting their data so that it inflated the scale of their testing programs and made it impossible to determine how many active infections they were probably missing. The problem has since been corrected.
Only seven states and the District of Columbia report testing data by race and ethnicity — indicators that can often point to virus trouble spots in some of the nation’s poorest communities. Many states have also changed how and when they report their testing data. This has led to wild swings in reported test positivities that have nothing to do with the virus’s spread.
Last week, the governor of New York and the mayor of New York City disagreed on whether a threshold of 3 percent positivity had been breached in the city. The mayor said it had and closed the schools; the governor said it had not. “The cause of the discrepancy,” according to The Times, lay “in both the tests that are included and the time frame in which statistics are reported.” This inconsistency can be the difference between shutting down schools and indoor dining, for instance, or not.
Inconsistent data also limits how reliably positivity can serve as an early warning about demand for hospital beds and medical equipment. Making informed comparisons between states requires having similar data to compare.
Confused by the terms about coronavirus testing? Let us help:
- Antibody: A protein produced by the immune system that can recognize and attach precisely to specific kinds of viruses, bacteria, or other invaders.
- Antibody test/serology test: A test that detects antibodies specific to the coronavirus. Antibodies begin to appear in the blood about a week after the coronavirus has infected the body. Because antibodies take so long to develop, an antibody test can’t reliably diagnose an ongoing infection. But it can identify people who have been exposed to the coronavirus in the past.
- Antigen test: This test detects bits of coronavirus proteins called antigens. Antigen tests are fast, taking as little as five minutes, but are less accurate than tests that detect genetic material from the virus.
- Coronavirus: Any virus that belongs to the Orthocoronavirinae family of viruses. The coronavirus that causes Covid-19 is known as SARS-CoV-2.
- Covid-19: The disease caused by the new coronavirus. The name is short for coronavirus disease 2019.
- Isolation and quarantine: Isolation is the separation of people who know they are sick with a contagious disease from those who are not sick. Quarantine refers to restricting the movement of people who have been exposed to a virus.
- Nasopharyngeal swab: A long, flexible stick, tipped with a soft swab, that is inserted deep into the nose to get samples from the space where the nasal cavity meets the throat. Samples for coronavirus tests can also be collected with swabs that do not go as deep into the nose — sometimes called nasal swabs — or oral or throat swabs.
- Polymerase Chain Reaction (PCR): Scientists use PCR to make millions of copies of genetic material in a sample. Tests that use PCR enable researchers to detect the coronavirus even when it is scarce.
- Viral load: The amount of virus in a person’s body. In people infected by the coronavirus, the viral load may peak before they start to show symptoms, if symptoms appear at all.
Without a federal standard, the data also becomes more susceptible to political influence. By deciding how many tests to offer and prioritizing certain groups for testing, local officials can artificially slow rising positivity rates. Recently, suspicions were raised among public health officials in New York when skyrocketing positivity in one community suddenly reversed course.
Covid-19 is surging and hospital capacity is again being stretched. Disparities are deepening, with Black and Latino patients more likely to be hospitalized and die from Covid-19. Since May, our institution, Johns Hopkins, has generated state-by-state positivity calculations, and it is clear to us that the lack of reporting standards for testing data is hindering the U.S. response to the virus.
This is inexcusable. As the pandemic accelerates to new levels of transmission every day, we urgently need a federal standard to guide testing and inform public health responses. That’s the reason we test and track the results in the first place.
Beth Blauer, the executive director of the Johns Hopkins University Centers for Civic Impact, and Jennifer Nuzzo, an associate professor of epidemiology in the Johns Hopkins Bloomberg School of Public Health and a senior fellow for global health at the Council on Foreign Relations, are on the leadership team of the Johns Hopkins Coronavirus Resource Center.
The Times is committed to publishing a diversity of letters to the editor. We’d like to hear what you think about this or any of our articles. Here are some tips. And here’s our email: email@example.com.
Saved Stories – None